靶向急性髓系白血病中的表观遗传-免疫轴：当前进展与未来方向

Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.

慢性淋巴细胞白血病/小淋巴细胞淋巴瘤中枢神经系统受累的当前管理

Current management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma.

一线二代 TKI 治疗 CML 后的无治疗缓解与免疫谱分析

Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.

抗 CD22/CD19 CAR-T 细胞疗法 CAR-T2219.1 在成人和儿童复发/难治性 B-ALL 中的 I/II 期试验

A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

癌症免疫治疗学会（SITC）关于急性白血病免疫治疗的临床实践指南，2.0 版

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0.

靶向白血病干细胞的脂质体纳米免疫疗法通过沉默 B 细胞淋巴瘤 2 逆转免疫逃逸并抑制融合癌蛋白驱动的急性髓系白血病

Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silen

免疫效应细胞相关肠炎的组织学谱系与 T 细胞克隆性特征

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

治疗相关谱系转换与克隆演化在难治性 NUP98::NSD1 重排急性白血病中的作用

Therapy-Associated Lineage Switch and Clonal Evolution in Refractory NUP98::NSD1-Rearranged Acute Leukemia.

新疗法时代移植后复发急性淋巴细胞白血病的结局：一项英国多中心回顾性研究

Outcomes for post-transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study.

CD84 在急性髓系白血病不同疾病阶段和白血病亚群中的表达

CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia.

结合现有的临床前和临床证据，这些发现支持继续评估靶向CD84的免疫疗法，包括CAR T细胞疗法，在AML中的应用。